Cystatin C, renal disease, amyloidosis and antibiotics
41 – 50 of 128
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids
(
- Contribution to journal › Article
- 1999
-
Mark
Cystatin C deficiency in human atherosclerosis and aortic aneurysms
(
- Contribution to journal › Article
- 1998
-
Mark
Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells
(
- Contribution to journal › Article
-
Mark
Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration
(
- Contribution to journal › Article
-
Mark
Serum cystatin C as a determinant of glomerular filtration rate in children
(
- Contribution to journal › Article
-
Mark
Screening for weak monoclonal antibodies in hybridoma technology
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Affinity screening for weak monoclonal antibodies
(
- Contribution to journal › Article
-
Mark
The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C
(
- Contribution to journal › Article
- 1997
-
Mark
Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes
(
- Contribution to journal › Article
-
Mark
Cystatin C, and inhibitor of bone resorption produced by osteoblasts
(
- Contribution to journal › Article